Dasatinib

In the US, Dasatinib (dasatinib systemic) is a member of the drug class BCR-ABL tyrosine kinase inhibitors and is used to treat Acute Lymphoblastic Leukemia, Chronic Myelogenous Leukemia and Leukemia.

US matches:

Scheme

Rec.INN

ATC (Anatomical Therapeutic Chemical Classification)

L01XE06

CAS registry number (Chemical Abstracts Service)

0302962-49-8

Chemical Formula

C22-H26-Cl-N7-O2-S

Molecular Weight

488

Therapeutic Category

Antineoplastic agent: Tyrosine kinase inhibitor

Chemical Names

N-(2-chloro-6-methylphenyl)-2-({6-[4-(2-hydroxyethyl)piperazin-1-yl]-2-methylpyrimidin-4-yl}amino)-1,3-thiazole-5-carboxamide (WHO)

2-{6-[4-(2-Hydroxyethyl)piperazin-1-yl]-2-methylpyrimidin-4-ylamino}thiazol-5-carbonsäure-(2-chlor-6-methylphenyl)amid (IUPAC)

5-Thiazolecarboxamide-N-(2-chloro-6-methylphenyl)-2-[[6-[4-(2-hydroxyethyl)-1-piperazinyl]-2-methyl-4-pyrimidinyl]amino]-

Foreign Names

  • Dasatinibum (Latin)
  • Dasatinib (German)
  • Dasatinib (French)
  • Dasatinib (Spanish)

Generic Names

  • Dasatinib (OS: BAN)
  • BMS 354825 (IS: Bristol-Myers)
  • Dasatinib (OS: USAN)
  • BMS-354825-03 (IS)
  • UNIIRBZ157X5H (IS)

Brand Names

  • Fontrax
    Richet, Argentina
  • Sprycel
    Bristol-Myers Squibb, Australia; Bristol-Myers Squibb, Canada; Bristol-Myers Squibb, Switzerland; Bristol-Myers Squibb, Colombia; Bristol-Myers Squibb, Denmark; Bristol-Myers Squibb, Greece; Bristol-Myers Squibb, Hong Kong; Bristol-Myers Squibb, Indonesia; Bristol-Myers Squibb, Ireland; Bristol-Myers Squibb, Israel; Bristol-Myers Squibb, India; Bristol-Myers Squibb, Iceland; Bristol-Myers Squibb, South Korea; Bristol-Myers Squibb, Lithuania; Bristol-Myers Squibb, Malaysia; Bristol-Myers Squibb, New Zealand; Bristol-Myers Squibb, Poland; Bristol-Myers Squibb, Romania; Bristol-Myers Squibb, Russian Federation; Bristol-Myers Squibb, Singapore; Bristol-Myers Squibb, Slovenia; Bristol-Myers Squibb, Thailand; Bristol-Myers Squibb, Tunisia; Bristol-Myers Squibb, Turkey; Bristol-Myers Squibb, Taiwan; Bristol-Myers Squibb, South Africa; Bristol Myers Squibb, Spain; Bristol Myers Squibb, Latvia; Bristol-Myers Squibb, Argentina; Bristol-Myers Squibb, Austria; Bristol-Myers Squibb, Belgium; Bristol-Myers Squibb, Chile; Bristol-Myers Squibb, Czech Republic; Bristol-Myers Squibb, Germany; Bristol-Myers Squibb, Finland; Bristol-Myers Squibb, France; Bristol-Myers Squibb, United Kingdom; Bristol-Myers Squibb, Hungary; Bristol-Myers Squibb, Italy; Bristol-Myers Squibb, Japan; Bristol-Myers Squibb, Netherlands; Bristol-Myers Squibb, Norway; Bristol-Myers Squibb, Oman; Bristol-Myers Squibb, Portugal; Bristol-Myers Squibb, Sweden; Bristol-Myers Squibb, United States; Bristol-Myers Squibb Phar, Luxembourg; PharmaSwiss, Croatia (Hrvatska)

International Drug Name Search

Glossary

TermDefinition
BANBritish Approved Name
IUPACInternational Union of Pure and Applied Chemistry
ISInofficial Synonym
OSOfficial Synonym
Rec.INNRecommended International Nonproprietary Name (World Health Organization)
USANUnited States Adopted Name
WHOWorld Health Organization

Click for further information on drug naming conventions and International Nonproprietary Names.

Important Notice: The Drugs.com international database is in BETA release. This means it is still under development and may contain inaccuracies. It is not intended as a substitute for the expertise and judgement of your physician, pharmacist or other healthcare professional. It should not be construed to indicate that the use of any medication in any country is safe, appropriate or effective for you. Consult with your healthcare professional before taking any medication.

Hide
(web2)